[The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
Villatte-cathelineau
B
B
D001519:Behavior; D001695:Biology; D002241:Carbohydrates; D002319:Cardiovascular System; D002560:Cerebrovascular Circulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003920:Diabetes Mellitus; D004194:Disease; D004702:Endocrine Glands; D004703:Endocrine System; D005123:Eye; D005193:Family Planning Services; D005947:Glucose; D006973:Hypertension; D008055:Lipids; D008660:Metabolism; D010827:Physiology; D011248:Pregnancy Complications; D012160:Retina; D012907:Smoking; D012919:Social Behavior; D013812:Therapeutics; D014652:Vascular Diseases
D002241:Carbohydrates; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D008055:Lipids; D005947:Glucose
Behavior; Biology; Carbohydrate Metabolic Effects; Cardiovascular Effects; Cerebrovascular Effects; Contraception--complications; Contraceptive Agents, Female--complications; Contraceptive Agents--complications; Contraceptive Methods--complications; Diabetes Mellitus; Diseases; Endocrine Effects; Endocrine System; Family Planning; Glucose Metabolism Effects; Hypertension; Lipid Metabolic Effects; Metabolic Effects; Ophthalmological Effects; Oral Contraceptives--complications; Physiology; Pregnancy Complications; Retinal Effects; Smoking; Social Behavior; Treatment; Vascular Diseases